HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Compound

Dimenhydrinate

HCID 10660
New reaction
Print

Completing data — refresh the page later to see the latest

Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
523-87-5
Standard SMILES
CN(C)CCOC(c1ccccc1)c1ccccc1.Cn1c(=O)c2[nH]c(Cl)nc2n(C)c1=O
InChIKey
NFLLKCVHYJRNRH-UHFFFAOYSA-N
Molecular formula
C17H21NO.C7H7ClN4O2
Average molar mass
470 g/mol
Monoisotopic mass
469.1880675

Overview

Dimenhydrinate is a crystalline white powder. (NTP, 1992)

Names & identifiers

Preferred name
Dimenhydrinate
IUPAC
2-benzhydryloxy-N,N-dimethylethanamine;8-chloro-1,3-dimethyl-7H-purine-2,6-dione
English name
Dimenhydrinate
Molecular formula
C17H21NO.C7H7ClN4O2
Molecular weight
469.97

Names & synonyms

DIMENHYDRINATE523-87-5DramamineTravelinDiphenhydrinateAnautineVomex AAmosytChloranautineAviomarinDromylGravol
Show more names
DIMENHYDRINATemesephaDiMatedramylemedylfaston
MenhydrinateAndramineDiamarinDramaminDramarinPermitalSupremalTeodramin

Database identifiers

CAS
523-87-5
PubChem CID
10660
DTXSID
DTXSID9025087
ChEMBL
CHEMBL1200406
ChEBI
CHEBI:94848
UNII
JB937PER5C
EC Number
208-350-8

Properties

Computed structural propertiesFilling in

Topological polar surface area
81.8 Ų
Hydrogen bond donors
1
Hydrogen bond acceptors
5
Rotatable bonds
6
Heavy atoms
33
Formal charge
0
Complexity
509

Experimental & physicochemical properties

pHSATURATED SOLN HAS PH BETWEEN 6.8 & 7.3
OdorODORLESS
Color/Form · 2 items

CRYSTALS

WHITE POWDER

Solubility · 2 items

Slightly soluble (1-10 mg/ml at 72 °F) (NTP, 1992)

FREELY SOL IN ALCOHOL, CHLOROFORM; SOL IN BENZENE; SOL IN WATER: ABOUT 3 MG/ML; ALMOST INSOL IN ETHER

Human Drugs · 3 items

Breast Feeding; Lactation; Antihistamines; Antiemetics; Gastrointestinal Agents

FDA approved drugs -> Active ingredient

FDA approved drugs -> Active ingredient

Melting Point · 3 items

216 to 225 °F (NTP, 1992)

103-104

102-107 °C

Physical DescriptionDimenhydrinate is a crystalline white powder. (NTP, 1992)

Physicochemical properties

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

GHS classification

GHS Classification · 4 items

Danger

H302 (99%): Harmful if swallowed [Warning Acute toxicity, oral]

P260, P261, P262, P264, P264+P265, P270, P271, P280, P284, P301+P317, P302+P352, P304+P340, P305+P351+P338, P316, P319, P320, P321, P330, P332+P317, P337+P317, P361+P364, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 105 reports by companies from 5 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Hazard information

Regulatory Information1H-Purine-2,6-dione, 8-chloro-3,7-dihydro-1,3-dimethyl-, compd. with 2-(diphenylmethoxy)-N,N-dimethylethanamine (1:1): Does not have an individual approval but may be used under an appropriate group standard
Other Safety InformationIMAP assessments - 1H-Purine-2,6-dione, 8-chloro-3,7-dihydro-1,3-dimethyl-, compound with 2-(diphenylmethoxy)-N,N-dimethylethanamine (1:1): Environment tier I assessment
Fire HazardsFlash point data for this compound are not available but it is probably non-flammable. (NTP, 1992)
Health Hazards · 1 item

SYMPTOMS: Symptoms associated with this compound include: drowsiness, lethargy, fatigue hypnosis and coma. Initial sedation may be followed by central nervous system hyperexcitability. Also, the victim may experience dry mouth, anorexia, nausea, vomiting, abdominal distress, constipation, and/or diarrhea. (NTP, 1992)

Reactive GroupAmides and Imides
Air and Water ReactionsSlightly soluble in water. Slightly acidic.

Chemistry & industry

Pharmacology

ATC Code · 2 items

R - Respiratory system

QR - Respiratory system

Protein BindingDimenhydrinate is 70-85% protein bound in plasma.
Pharmacodynamics · 1 item

Dimenhydrinate is indicated for the prevention and treatment of nausea, vomiting, or vertigo of motion sickness. It has a short duration of action of 4-8 hours. Patients should be counselled regarding pronounced drowsiness, avoiding alcohol and other sedatives, and exercising caution when operating a motor vehicle or heavy machinery.

Mechanism of Action · 5 items

Dimenhydrinate is a theoclate salt that separates into [diphenhydramine] and [8-chlorotheophylline]. While the exact mechanism of action is unknown, diphenhydramine is theorized to reduce disturbances to equilibrium through antimuscarinic effects or histamine H1 antagonism. 8-chlorotheophylline may produce excitation through blocking adenosine receptors, reducing the drowsiness produced by diphenhydramine.

IT IS ESSENTIAL TO NOTE THAT NEITHER H1...BLOCKERS INHIBIT HISTAMINE RELEASE. ...EFFECTS OF HISTAMINE ANTAGONISTS...FACILITATE RELEASE. BENEFICIAL EFFECTS OF HISTAMINE ANTAGONISTS ARE THUS CONFINED TO ANTAGONISM OF RESPONSES TO HISTAMINE THAT IS RELEASED. /ANTIHISTAMINES/

DRUGS USED TO BLOCK HISTAMINE RECEPTORS FALL INTO THAT LARGE GROUP OF PHARMACOLOGICAL ANTAGONISTS THAT APPEAR TO ACT BY OCCUPYING "RECEPTIVE SITES" ON EFFECTOR CELL, TO EXCLUSION OF AGONIST MOLECULES, WITHOUT THEMSELVES INITIATING RESPONSE. TYPICALLY...COMPETITIVE & REVERSIBLE. /ANTIHISTAMINES/

...ANTIHISTAMINES EFFECTIVE IN MOTION SICKNESS ACT BY VIRTUE OF CENTRAL ANTAGONISM OF ACH... ACT BY BLOCKING EXCITATORY LABYRINTHINE IMPULSES @ CHOLINERGIC SYNAPSES IN REGION OF VESTIBULAR NUCLEI. /ANTIHISTAMINES/

...MOTION SICKNESS. ...STIMULATION OF VESTIBULAR APPARATUS...& THAT VESTIBULAR CEREBELLAR MIDBRAIN "INTEGRATIVE VOMITING CENTER" & MEDULLARY CHEMORECEPTIVE TRIGGER ZONE ARE SOMEHOW INVOLVED. /ANTIHISTAMINES/

Biological Half-LifeThe plasma elimination half life of dimenhydrinate is 5-8 hours.
Metabolism/Metabolites

Related reactions

0 records
New reaction record
No related reactions yet

Compound notes

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Melting point
102 · 102-107°C
Density
1.2586 · 1.2586 (rough estimate)
refractive index
1.65 · 1.6500 (estimate)
storage temp.
Inert atmosphere,Room Temperature
solubility
Slightly soluble in water, freely soluble in ethanol (96 per cent).
form
Solid
color
White to Off-White
Water Solubility
Slightly soluble (0.1-1 g/100 mL at 22 ºC)
Stability
Hygroscopic
InChIKey
NFLLKCVHYJRNRH-UHFFFAOYSA-N
CAS DataBase Reference
523 · 523-87-5(CAS DataBase Reference)
FDA 21 CFR
336.1 · 336.10
FDA UNII
937 PER5C · JB937PER5C
EPA Substance Registry System
Dimenhydrinate (523-87-5)
Symbol(GHS)
7 · GHS07
Signal word
Warning
Hazard statements
302 · H302
Precautionary statements
301 · P301+P312+P330
Hazard Codes
Xn,Xi
Risk Statements
22 · 22-61-36/37/38
Safety Statements
22 · 22-26-36/37/39-53
WGK Germany
3 · 3
RTECS
5082000 · XH5082000
TSCA
TSCA listed
HS Code
2939590000 · 2939590000
Hazardous Substances Data
523 · 523-87-5(Hazardous Substances Data)
Hazard Classes and CategoriesAcute Tox. 4 (99%)

Safety & protection

Fire FightingFires involving this compound should be controlled using a dry chemical, carbon dioxide, foam or Halon extinguisher. (NTP, 1992)
First Aid · 1 item

EYES: First check the victim for contact lenses and remove if present. Flush victim's eyes with water or normal saline solution for 20 to 30 minutes while simultaneously calling a hospital or poison control center. Do not put any ointments, oils, or medication in the victim's eyes without specific instructions from a physician. IMMEDIATELY transport the victim after flushing eyes to a hospital even if no symptoms (such as redness or irritation) develop.

Nonfire Spill Response · 1 item

SMALL SPILLS AND LEAKAGE: Should a spill occur while you are handling this chemical, you should dampen the solid spill material with alcohol, then transfer the dampened material to a suitable container. Use absorbent paper dampened with alcohol to pick up any remaining material. Seal the absorbent paper, and any of your clothes, which may be contaminated, in a vapor-tight plastic bag for eventual disposal. Solvent wash all contaminated surfaces with alcohol followed by washing with a strong soap and water solution. Do not reenter the contaminate area until the Safety Officer (or other responsible person) has verified that the area has been properly cleaned.

Personal Protective Equipment (PPE) · 1 item

RECOMMENDED RESPIRATOR: Where the neat test chemical is weighed and diluted, wear a NIOSH-approved half face respirator equipped with an organic vapor/acid gas cartridge (specific for organic vapors, HCl, acid gas and SO2) with a dust/mist filter. (NTP, 1992)

Toxicology

Interactions · 2 items

CHLORPHENIRAMINE COULD THEORETICALLY PREVENT BETA-ADRENERGIC BLOCKING EFFECT OF PROPRANOLOL & ENHANCE ITS QUINIDINE-LIKE EFFECT. .../ANTIHISTAMINES/ ARE SIMILAR TO CHLORPHENIRAMINE IN THEIR ACTIONS. OTHER ANTIHISTAMINES INCL...DIMENHYDRINATE...

PATIENTS RECEIVING ANTIHISTAMINES SHOULD BE WARNED AGAINST THE CONCOMITANT USE OF ALCOHOLIC BEVERAGES OR OTHER DRUGS THAT DEPRESS CNS... /ANTIHISTAMINES/

HepatotoxicityDespite widespread use, dimenhydrinate has not been linked to liver test abnormalities or to clinically apparent liver injury. The reason for its safety may relate to its limited duration of use.
Human Toxicity Excerpts · 5 items

...POSSESS SIGNIFICANT ANTICHOLINERGIC ACTIVITY & HAVE PRONOUNCED TENDENCY TO INDUCE SEDATION. /ETHANOLAMINES/

SIDE EFFECT WITH HIGHEST INCIDENCE...IS SEDATION. ... OTHER...REFERABLE TO CENTRAL ACTIONS INCL DIZZINESS, TINNITUS, LASSITUDE, INCOORDINATION, FATIGUE, BLURRED VISION, DIPLOPIA, EUPHORIA, NERVOUSNESS, INSOMNIA, & TREMORS. /ANTIHISTAMINES/

...SIDE EFFECTS...DIGESTIVE TRACT...LOSS OF APPETITE, NAUSEA, VOMITING, EPIGASTRIC DISTRESS, & CONSTIPATION OR DIARRHEA. ...DRYNESS OF MOUTH, THROAT & RESP PASSAGES...COUGH; URINARY FREQUENCY & DYSURIA; PALPITATION, HYPOTENSION, HEADACHE; TIGHTNESS OF CHEST; & TINGLING, HEAVINESS & WEAKNESS OF HANDS. /ANTIHISTAMINES/

IN SMALL CHILD, DOMINANT EFFECT IS EXCITATION...INCL HALLUCINATIONS, EXCITEMENT, ATAXIA, INCOORDINATION, ATHETOSIS, & CONVULSIONS. ...OF INTERMITTENT TONIC-CLONIC TYPE... FIXED, DILATED PUPILS WITH FLUSHED FACE & FEVER... TERMINALLY...DEEPENING COMA WITH CARDIORESPIRATORY COLLAPSE & DEATH... /ANTIHISTAMINES/

For more Human Toxicity Excerpts (Complete) data for DIMENHYDRINATE (9 total), please visit the HSDB record page.

Drug Induced Liver Injury · 6 items

Drug Induced Liver Injury Rank (DILIrank 2.0)

Dimenhydrinate

vNo-DILI-concern

0

No match

DOI:10.1016/j.drudis.2016.02.015

Non-Human Toxicity Excerpts · 2 items

DIMENHYDRAMINE...WAS FOUND NOT TO BE TERATOGENIC TO SPRAGUE-DAWLEY RATS WHEN GIVEN THROUGHOUT PREGNANCY BEGINNING 3 DAYS BEFORE CONCEPTION.

...IN GUINEA PIGS PROTECTED FROM HISTAMINE-INDUCED ASPHYXIAL DEATH BY H1-BLOCKING DRUGS. ...MAY SUBSEQUENTLY DIE FROM PERFORATED ULCERATION AS RESULT OF GASTRIC HYPERSECRETION. /ANTIHISTAMINES/

Effects During Pregnancy and Lactation◉ Summary of Use during Lactation

Safety data

wgk
3
tsca
TSCA listed
rtecs
XH5082000
hs_code
2939590000
risk_code
22-61-36/37/38
Signal word
Warning
Symbol(GHS)
GHS07
hazard_code
Xn,Xi
safety_code
22-26-36/37/39-53
Hazard statements
H302
Precautionary statements
P301+P312+P330
Hazardous Substances Data
523-87-5(Hazardous Substances Data)
· 2 items

Dimenhydrinate is a theoclate salt that separates into [diphenhydramine] and [8-chlorotheophylline]. diphenhydramine can either be N-glucuronidated by UGTs to diphenhydramine N-glucuronide or N-demethylated by CYP2D6, CYP1A2, CYP2C9, and CYP2C19 to N-desmethyldiphenhydramine. N-desmethyldiphenhydramine can be N-demethylated again by the same enzymes to N,N-didesmethyldiphenhydramine, which undergoes oxidative deamination to form diphenylmethoxyacetic acid.

EXTENSIVE STUDIES OF METABOLIC FATE OF ANTIHISTAMINES HAVE BEEN LIMITED TO A FEW COMPD. ... MAIN SITE OF METABOLIC TRANSFORMATION IS LIVER. /ANTIHISTAMINES/

FDA Pharmacological Classification · 2 items

DIMENHYDRINATE

Histamine-1 Receptor Antagonist [EPC]; Histamine H1 Receptor Antagonists [MoA]

MeSH Pharmacological Classification · 2 items

Drugs used to prevent NAUSEA or VOMITING.

Drugs that selectively bind to but do not activate histamine H1 receptors, thereby blocking the actions of endogenous histamine. Included here are the classical antihistaminics that antagonize or prevent the action of histamine mainly in immediate hypersensitivity. They act in the bronchi, capillaries, and some other smooth muscles, and are used to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence. The effects of blocking central nervous system H1 receptors are not as well understood.

Absorption, Distribution and Excretion · 5 items

A 50 mg oral film coated tablet reaches a Cmax of 72.6 ng/mL with a Tmax of 2.7 hours. A 100 mg suppository reaches a Cmax of 112.2 ng/mL with a Tmax of 5.3 hours.

Dimenhydrinate is predominantly eliminated in the urine. 1-3% of the dissociated diphenhydramine is eliminated in the urine unchanged, while 64% of diphenhydramine is eliminated in the urine as metabolites. The elimination of dimenhydrinate has not been fully studied.

The volume of distribution of dimenhydrinate is 3-4 L/kg.

DIMENHYDRINATE (ETHANOLAMINES): DURATION OF ACTION (HR) 4-6. /FROM TABLE/

H1 ANTAGONISTS ARE READILY ABSORBED FROM GI TRACT & PARENTERAL SITES OF ADMIN. FOLLOWING ORAL ADMIN, EFFECTS START WITHIN 15 TO 30 MIN, ARE FULLY DEVELOPED WITHIN 1 HR, & LAST ABOUT 3 TO 6 HR, ALTHOUGH SOME...ACT LONGER. /ANTIHISTAMINES/

Uses & manufacturing

Uses · 3 items

MEDICATION

MEDICATION (VET)

Use (kg; approx.) in Germany (2009): >7500

Methods of Manufacturing · 2 items

CUSIC, SCIENCE 109, 574 (1949); CUSIC, US PATENTS 2,499,058 & 2,534,813 (1950 TO SEARLE).

BY CAUSING DIMETHYLAMINOETHYL BENZHYDRYL ETHER TO COMBINE WITH 8-CHLOROTHEOPHYLLINE BY REFLUXING ISOPROPYL ALCOHOL SOLN. CRYSTALLINE PPT OF DIMENHYDRINATE WHICH FORMS ON COOLING IS COLLECTED BY FILTRATION, WASHED WITH COLD ETHYL ACETATE & DRIED.

Formulations/Preparations · 2 items

INJECTION: 50 MG/ML; SUPPOSITORIES: 100 MG; SYRUP USP: 15 MG/5 ML; TABLETS USP: 50 MG.

...CONTAINS 53-55.5% OF DIPHENYLHYDRAMINE (C17-H21-N-O), & 44.47% OF 8-CHLOROTHEOPHYLLINE (C7-H7-CL-N4-O2).

General Manufacturing Information1H-Purine-2,6-dione, 8-chloro-3,7-dihydro-1,3-dimethyl-, compd. with 2-(diphenylmethoxy)-N,N-dimethylethanamine (1:1): ACTIVE
Applications · 7 items

UsesIt is suitable for motion-sickness, pregnancy, radiation therapy , surgery etc. induced nausea , vomiting and dizziness.

DescriptionDimenhydrinate (16.1.2) is a complex compound of N, N-dimethyl (2- diphenylmethoxy)ethylamine—diphenhydramine with 8-chlorotheophylline. While blocking the H1 receptor, dimenhydrinate simultaneously acts on the vomiting center.

UsesDimenhydrinate is used for preventing and stopping sea or airsickness, and for nausea and vomiting. Synonyms of this drug are dramamine, dadalon, emedyl, travelin, and others.

UsesAn antihistamine with antiemetic properties used to prevent nausea and motion sicknes composed of two drugs 8-Chlorotheophylline (C411440) and Diphenhydramine (D486900).

UsesUsed for treating vertigo, motion sickness, and nausea associated with pregnancy

General DescriptionThe 8-chlorotheophyllinate (theoclate) salt of diphenhydramine, 8-chlorotheophylline 2-(diphenylmethoxy)-N,N-dimethylethylamine (Dramamine), is a white crystalline, odorless powder that is highly soluble in water and freely soluble in alcohol and chloroform. Dimenhydrinate is recommended for nausea of motion sickness and for hyperemesis gravidarum (nausea of pregnancy).

General DescriptionCrystalline white powder.

Upstream & downstream products

Upstream raw materials

8-Chlorotheophylline
Additional notes · 1 item

DefinitionChEBI: The diphenhydramine salt of 8-chlorotheophylline. Its effects are similar to those of diphenhydramine, but it is less potent. It was thought that by combining the antiemetic effects of diphenhydramine with the mild stimulant effects of 8-chlorotheophyline, the extreme drowsiness induced by the former would be mitigated. However, the sedation caused by diphenhydramine is considerably stronger than the stimulation caused by 8-chlorotheophylline. Dimenhydrinate is used mainly as an antiemetic in the prevention nd treatment of motion sickness.